Jump to section
Ophelia's mission is to reinvent the drug rehab model - to replace folklore with science, drug dealers with doctors, and stigma with privacy, convenience, and choice.
Effective rehab is vital to getting off drugs. However, the science is clear: rehab fails 90% of the time when not followed by medication. With over 90,000 drug-involved overdose deaths in the US alone in 2020, it is clear that there is a pressing need to bring about effective treatment for addiction.
This is what Ophelia wants to fix. Ophelia makes medical best practices for Opioid Use Disorder (OUD) private, convenient, and accessible, using a novel telehealth platform to provide FDA-approved medications, chronic support, and therapy at low cost. Reportedly 6x more effective than most rehabs, Ophelia has real potential to help thousands of patients looking to get off opioids.
The opioid crisis in the US has continued to grow over the past decade, and this has led to a host of new treatment solutions popping up. As well as conventional rehab methods, Ophelia will face direct competition from platforms like Cerebral. However, having secured major funding across multiple rounds, it is well placed to make a real impact on a key social issue.
Freddie
Company Specialist at Welcome to the Jungle
Dec 2021
$50m
SERIES B
Apr 2021
$15m
SERIES A
This company has top investors
Zack Gray
(CEO)Previously Head of Growth at Level Solar.